fda stopping compounded semaglutide compounding news FDA moves to stop compounding GLP-1 drugs versions of weight loss – Compounded Semaglutide: Legal & Safe

The compound works through a unique mechanism involving G-actin sequestration, which essentially maintains a reservoir of cellular building blocks ready for rapid deployment when tissue repair is needed

Palafox, M

Early evidence suggests that individuals using GLP-1s spend significantly less money at the grocery store, shifting their purchasing habits away from snacks, alcohol, and carbohydrates while also increasing demand for high-protein and nutrient-dense foods (e.g., Roe, 2025

A patient with a genetic predisposition toward higher GLP1R sensitivity might experience more pronounced appetite reduction and stricter food-volume limitations

They also come with side effects, and every so often, with genuinely serious complications